A Study of Mezigdomide in Healthy Participants and Participants With Hepatic Impairment
Clinical trial NCT05707390 · COMPLETED
Trial details
- NCT number
- NCT05707390
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-20
- Primary completion
- 2023-09-13
- Enrollment
- 32
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.